α
AlphaScala
StocksSignalsNEWAlpha ScoreBrokers
Sign InGet Started
α
AlphaScala

Professional trading analysis with publicly tracked portfolios on TipRanks. Real trades, real data.

Markets

ForexStocksCryptoCommodities

Tools

Stock ResearchMarket SignalsAlpha ScoreHedge Funds 13FInsider BuysAgentic TradingAI Broker MatcherBroker ReviewsPortfoliosFree IndicatorsBlogLearn TradingTrading Q&A

Account

Sign InDashboardNewsletterContact UsAdvertise

Legal

AboutEditorial PolicyCorrectionsTerms of ServicePrivacy PolicyRisk Disclaimer

Risk Warning: AlphaScala provides educational content only and is not a financial advisor. Trading and investing involves substantial risk of loss and is not suitable for all investors. Past performance does not guarantee future results. You should consult a licensed financial advisor before making investment decisions. See our full risk disclaimer.

For AI AgentsAlphaScala is agent-ready —skill.md·llms.txt
© 2026 ROGA AI LIMITED · Registered in Gibraltar · Unit G02, Eurocity, Europort Avenue, Gibraltar GX11 1AAAlphaScala — Built with data, not hype.
All Stocks/Healthcare/HIMS

Hims & Hers Health, Inc.

HIMS
HealthcareDrug Manufacturers - Specialty & Generic Website
Signal SnapshotMarket signals →
Alpha Score
Score pending
Alpha Score appears once the required price and fundamentals data has ingested.
Daily model
Insiders
No recent signal
No recent open-market insider buying or selling is in the current rollup.
Form 4
13F Holder
Citadel
$424.55M reported position; latest action: new.
Ken Griffin
Latest Filing
No filing digest
Recent 10-K, 10-Q, and 8-K summaries will appear here when available.
SEC digest
Price ChartPowered by TradingView
Ask about HIMSAI research agent
Top Institutional HoldersFrom 13F filings
FundShares HeldPosition ValueAction (latest Q)
Citadel
Ken Griffin
13.08M$424.55MNEW
Renaissance Technologies
Jim Simons (founder)
4.82M$156.44MNEW
D.E. Shaw
David Shaw
4.68M$151.96MNEW
Point72
Steve Cohen
667K$21.67MNEW
Marshall Wace6K$204.5KNEW
Explore all tracked funds →
About Hims & Hers Health, Inc.

Hims & Hers Health, Inc. is a leading telehealth platform that connects consumers to licensed healthcare professionals for personalized medical care. The company operates a direct-to-consumer model, offering consultations, prescription medications, over-the-counter products, and wellness solutions across specialties including sexual health, hair care, skincare, mental health, weight loss, dermatology, and primary care. Customers engage through a secure online intake process, receive evaluations from vetted providers in all 50 U.S. states and internationally in countries like the United Kingdom, Canada, Germany, France, Spain, and Ireland, and access treatments shipped discreetly from partner pharmacies. Hims & Hers emphasizes asynchronous messaging for convenience, ongoing clinical support, educational resources, laboratory testing for biomarkers, and curated non-prescription items such as supplements, cosmetics, and devices focused on general wellness. Founded in 2017 and headquartered in San Francisco, California, the platform prioritizes clinical quality, customer privacy, and accessibility to normalize health challenges and empower informed decisions.

CEO
Mr. Andrew Dudum
Employees
2,442
Quick Facts
Exchange—
SectorHealthcare
IndustryDrug Manufacturers - Specialty & Generic
Market Cap—
Popular Stocks
AAPL
Apple Inc.
MSFT
Microsoft Corporation
NVDA
NVIDIA Corporation
AMZN
Amazon.com Inc.
GOOGL
Alphabet Inc. Class A
GOOG
Alphabet Inc. Class C
META
Meta Platforms Inc.
TSLA
Tesla Inc.
Key Dates

Earnings calendar coming soon. Subscribe to get notified when HIMS reports next.

Get earnings alerts →